GGrantIndex
Sort

15,440 grants matching organoids

Elucidating the Molecular Role of SYNCRIP in Prostate Cancer and AR Targeted Therapy Resistance

$467,016
Ping Mu · Yale University · R37 · FY2024 · CA

Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation

$466,898
Xinna Zhang · Indiana University Indianapolis · R01 · FY2023 · CA

Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation

$466,898
Xinna Zhang · Indiana University Indianapolis · R01 · FY2025 · CA

Project 3: The AMPK Autophagy Pathway as a Metabolic Liability in Pancratic Ductal Adenocarcinoma

$466,752
Reuben J Shaw · Salk Institute For Biological Studies · P01 · FY2023 · CA

Project 3: The AMPK Autophagy Pathway as a Metabolic Liability in Pancratic Ductal Adenocarcinoma

$466,751
Reuben J Shaw · Salk Institute For Biological Studies · P01 · FY2025 · CA

Interferon-inducible cell-intrinsic host defense against Chlamydia trachomatis

$466,717
Joern Coers · Duke University · R01 · FY2019 · AI

Targeting APOBEC3A-induced genetic heterogeneity and drug resistance in bladder cancer

$466,426
Bishoy Morris Faltas · Weill Medical Coll Of Cornell Univ · R37 · FY2024 · CA

CellCelector Flex for versatile automated single cell and colony picking

$466,395
Molishree Umesh Joshi · University Of Colorado Denver · S10 · FY2025 · OD

Defining the impact of stromal aging on ovarian cancer initiation

$466,375
Lan Coffman · University Of Pittsburgh At Pittsburgh · U01 · FY2021 · AG

Metabolic flux analysis and PDX models to understand therapeutic vulnerabilities following inhibition of Ref-1 redox signaling in pancreatic cancer

$466,315
Mark R. Kelley · Indiana University Indianapolis · R01 · FY2023 · CA

The role of cortisol synthesis in pathogenesis of Hidradenitis suppurativa tunnels

$466,198
Marjana Tomic-Canic · University Of Miami School Of Medicine · R01 · FY2024 · AR

Characterizing the role of MSRA in pancreatic tumorigenesis

$466,179
Christine Iok In Chio · Columbia University Health Sciences · R01 · FY2023 · CA

The Role of the Microbiome and Notch Signaling in Esophageal Adenocarcinoma

$466,166
Julian Abrams · Columbia University Health Sciences · R01 · FY2025 · CA

Investigating the impact of inflammation on brain development using human cerebral organoids.

$466,125
Lotje Dorothee De Witte · Icahn School Of Medicine At Mount Sinai · R21 · FY2020 · MH

The impact of Alzheimer's disease susceptibility alleles on microglia transcriptome

$466,125
Towfique Raj · Icahn School Of Medicine At Mount Sinai · R21 · FY2020 · AG

Reprogram gastric tissue to functional insulin-secreting cells

$466,055
Qiao Joe Zhou · Harvard University · R01 · FY2017 · DK

Reprogram gastric tissue to functional insulin-secreting cells

$466,055
Qiao Joe Zhou · Harvard University · R01 · FY2018 · DK

Co-targeting BET Bromodomain Proteins and MNK Kinases in Pancreatic Cancer

$465,989
Hidayatullah G Munshi · Northwestern University At Chicago · R01 · FY2024 · CA

Functional Evaluation and Interpretation of DNA Damage Repair Variants in Prostate Cancer

$465,986
Charles L Sawyers · Sloan-Kettering Inst Can Research · P01 · FY2019 · CA

Comprehensive phenotypic and genetic assessment of trachealesophageal (TE) birth defects patients

$465,947
Paul Scot Kingma · Cincinnati Childrens Hosp Med Ctr · P01 · FY2019 · HD

Comprehensive phenotypic and genetic assessment of trachealesophageal (TE) birth defects patients

$465,947
Paul Scot Kingma · Cincinnati Childrens Hosp Med Ctr · P01 · FY2020 · HD

REGULATION OF ATROPHY-INDUCED PROGENITOR CELLS IN THE GASTRIC CORPUS

$465,896
Jason C Mills · Washington University · R01 · FY2020 · DK

Disease model design and evaluation

$465,890
Craig Thomas · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR

Chemoenzymatic methods for the detection of cellsurface glycans

$465,890
Peng Wu · Scripps Research Institute, The · R01 · FY2017 · GM

Colon cell mechanoregulation through an E-cadherin - associated RNAi machinery

$465,803
Antonis Kourtidis · Medical University Of South Carolina · R01 · FY2024 · DK